Ali Salanti

Ali Salanti

Professor

Member of:

  • VAR2CSA team

  • CMP-BIOENGINEERING

ORCID: 0000-0003-2207-5575

Publication year:
All
11 - 15 out of 15Page size: 10
  1. 2021
  2. Published

    Site-specific O-glycosylation analysis of SARS-CoV-2 spike protein produced in insect and human cells

    Bagdonaite, Ieva , Thompson, A. J., Wang, X., Søgaard, M., Fougeroux, Cyrielle Elyette, Frank, M., Diedrich, J. K., Yates, J. R., Salanti, Ali, Vakhrushev, Sergey, Paulson, J. C. & Wandall, Hans H., 2021, In: Viruses. 13, 4, 551.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    The development, fine specificity, and importance of high-avidity antibodies to VAR2CSA in pregnant Cameroonian women living in Yaoundé, an urban city

    Vanda, K., Bobbili, N., Matsunaga, M., Chen, J. J., Salanti, Ali, Leke, R. F. G. & Taylor, D. W., 2021, In: Frontiers in Immunology. 12, p. 610108

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    The immunogenicity of capsid-like particle vaccines in combination with different adjuvants using different routes of administration

    Janitzek, C. M., Carlsen, P. H. R., Thrane, Susan, Khanna, V. M., Jakob, V., Barnier-Quer, C., Collin, N., Theander, Thor Grundtvig, Salanti, Ali, Nielsen, Morten Agertoug & Sander, Adam F. , 2021, In: Vaccines. 9, 2, 131.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    The specificity of the malarial VAR2CSA protein for chondroitin sulfate depends on 4-O-sulfation and ligand accessibility

    Spliid, C. B., Toledo, A. G., Sanderson, P., Mao, Y., Gatto, F., Gustavsson, Tobias, Choudhary, Swati, Saldanha, A. L., Vogelsang, R. P., Gögenur, Ismail, Theander, Thor Grundtvig, Leach, F. E., Amster, I. J., Esko, J. D., Salanti, Ali & Clausen, Thomas Mandel, 2021, In: The Journal of Biological Chemistry. 297, 6, 15 p., 101391.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Two-component nanoparticle vaccine displaying glycosylated spike S1 domain induces neutralizing antibody response against SARS-CoV-2 variants

    van Oosten, L., Altenburg, J. J., Fougeroux, C., Geertsema, C., van den End, F., Evers, W. A. C., Westphal, A. H., Lindhoud, S., van den Berg, W., Swarts, D. C., Deurhof, L., Suhrbier, A., Le, T. T., Torres Morales, S., Myeni, S. K., Kikkert, M., Sander, A. F., de Jongh, W. A., Dagil, R., Nielsen, M. A. & 9 others, Salanti, Ali, Søgaard, M., Keijzer, T. M. P., Weijers, D., Eppink, M. H. M., Wijffels, R. H., van Oers, M. M., Martens, D. E. & Pijlman, G. P., 26 Oct 2021, In: mBio. 12, 5, e0181321.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 Next

ID: 4808